For more information on probiotics, visit http://www.probioticscenter.com.
Yakult Honsha Co., Ltd., headquartered in Tokyo, Japan, is the world's
pioneer in probiotics by introducing the first single shot probiotics
drink, Yakult(R), in 1935. Founded by microbiologist Dr. Minoru Shirota,
Yakult(R) contains high amounts of its signature strain, Lactobacillus
casei Shirota. Yakult is committed to researching the endless applications
for probiotics and the use of intestinal bacteria in human health around
the world. The company has established two science institutes to support
its efforts; one in Japan (Yakult Central Institute for Microbiological
Research) and one in Europe (Yakult Honsha European Research Center for
Microbiology ESV). Since developing its overseas network in 1964, Yakult
has expanded its business to 31 countries and territories. In addition to
producing the internationally recognized probiotic beverage, Yakult is also
accredited in the pharmaceutical field for its development of Campto
Injection (Camptosar), the first-line drug for colorectal cancer in the
U.S. Yakult U.S.A. Inc., the subsidiary of Yakult Honsha Co., Ltd., is
stationed in Torrance, CA. For more information, please visit
http://www.yakult.co.jp/english, http://www.yakult.co.jp/institute, ht
'/>"/>
| SOURCE The Dannon Company, Inc.; Yakult Honsha Co., Ltd. Copyright©2008 PR Newswire. All rights reserved |